FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer.
Saved in:
| Title: | FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer. |
|---|---|
| Authors: | Marmé, F.1,2 Frederik.Marme@med.uni-heidelberg.de, Werft, W.3, Benner, A.3, Burwinkel, B.1,4, Sinn, P.5, Sohn, C.1, Lichter, P.2, Hahn, M.2, Schneeweiss, A.1 |
| Source: | Annals of Oncology. Aug2010, Vol. 21 Issue 8, p1636-1642. 7p. 5 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdq017 |
